A Search Service for Abbreviation / Long Form

â–  Search Result - Abbreviation : EGFR

Search Conditions:
Search Keyword : EGFR
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: EGFR
Appearance Frequency: 24414 time(s)
Long forms: 72

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
epidermal growth factor receptor
(22597 times)
Neoplasms
(9276 times)
NSCLC (3834 times)
TKIs (1273 times)
PFS (1010 times)
0 [Effect of Erlotinib in 2nd and 3rd Line Anticancer Treatment in Patients with Squamous Cell Lung Cancer - Case Series].
EGF receptor
(1652 times)
Neoplasms
(397 times)
EGF (840 times)
NSCLC (67 times)
TGF-alpha (65 times)
1980 Genetic analysis of epidermal growth factor action: assignment of human epidermal growth factor receptor gene to chromosome 7.
anti-EGF receptor
(27 times)
Neoplasms
(15 times)
EGF (10 times)
mCRC (3 times)
NSCLC (3 times)
1994 [Growth control of a human glioma cell line by multiple autocrine loop blockade].
EGFRvIII
(27 times)
Neoplasms
(16 times)
GBM (6 times)
mAbs (2 times)
NSCLC (2 times)
1997 Epidermal growth factor receptor stimulation of diacylglycerol kinase.
EGF and its receptor
(15 times)
Biology
(2 times)
EGF (15 times)
CNS (1 time)
CNT (1 time)
1994 Modulation of epidermal growth factor binding and receptor gene expression by hormones and growth factors in sheep pituitary cells.
EGFRwt
(5 times)
Neoplasms
(5 times)
GBM (2 times)
OS (2 times)
EGFRvIII (1 time)
2003 Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
anti-EGFR Affibody molecule, Ac-Cys-Z
(4 times)
Radiotherapy
(1 time)
hEGF (1 time)
HNSCC (1 time)
p.i (1 time)
2010 Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount.
early growth factor receptor
(3 times)
Neoplasms
(1 time)
GNP (1 time)
GNPs (1 time)
2015 Amphiregulin Is a Critical Downstream Effector of Estrogen Signaling in ERalpha-Positive Breast Cancer.
Economic AnalysisEpidermal Growth Factor Receptor Mutation
(3 times)
Biomedical Technology
(3 times)
CCO (3 times)
MAS (3 times)
PEPP (3 times)
2010 Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
10  epidermal GFR
(3 times)
Metabolism
(1 time)
GFRs (2 times)
DCN (1 time)
ECM (1 time)
2011 Mast cell tryptase stimulates production of decorin by human testicular peritubular cells: possible role of decorin in male infertility by interfering with growth factor signaling.
11  epidermal growth receptor factor
(3 times)
Otolaryngology
(1 time)
AC (1 time)
NSCLC (1 time)
PET (1 time)
1995 [Proliferation behavior of cholesteatoma].
12  erlotinib, gefitinib
(3 times)
Neoplasms
(2 times)
NSCLC (3 times)
2008 Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor.
13  EGF and TGF alpha and their common receptor
(2 times)
Gastroenterology
(1 time)
EGF (1 time)
HP (1 time)
NO (1 time)
1992 Adaptation of gastric mucosa to chronic alcohol administration is associated with increased mucosal expression of growth factors and their receptor.
14  EGF binds to its cell surface receptor
(2 times)
Neoplasms
(2 times)
EGF (2 times)
AP-1 (1 time)
HNSCC (1 time)
2008 Fucoidan from Laminaria cichorioides inhibits AP-1 transactivation and cell transformation in the mouse epidermal JB6 cells.
15  EGF receptor gene
(2 times)
Neoplasms
(1 time)
aa (1 time)
CM (1 time)
GBM (1 time)
2013 Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy.
16  EGFR-siRNA
(2 times)
Gastroenterology
(1 time)
BE (1 time)
CDX2 (1 time)
EGF (1 time)
2012 The role of nitric oxide in the induction of caudal-type homeobox 2 through epidermal growth factor receptor in the development of Barrett's esophagus.
17  EGFR-TKIs
(2 times)
Neoplasms
(1 time)
NSCLC (2 times)
mOS (1 time)
mPFS (1 time)
2015 Experience with erlotinib in the treatment of non-small cell lung cancer.
18  EGFRt-EGFP
(2 times)
Neoplasms
(1 time)
EGF (1 time)
ERK (1 time)
GBM (1 time)
2004 Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme.
19  enhanced growth factor receptor
(2 times)
Cell Biology
(1 time)
CDDS (1 time)
GPCR (1 time)
MSNs (1 time)
2006 Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1.
20  epidermal GF receptor
(2 times)
Neurosurgery
(1 time)
GF (2 times)
CL (1 time)
DCN (1 time)
1999 Inhibition of phospholipase C-gamma1 activation blocks glioma cell motility and invasion of fetal rat brain aggregates.
21  Epidermal growth factor inhibitors
(2 times)
Dermatology
(1 time)
HNSCC (1 time)
2006 [Treatment of acneiform rash by epidermal growth factor inhibitors with oral tetracyclines].
22  epidermal receptor growth factor
(2 times)
Neoplasms
(1 time)
BCSS (1 time)
FISH (1 time)
IHC (1 time)
0 [Two perspectives on venous thromboembolism in oncology].
23  HB-EGF, the EGF receptor
(2 times)
Nephrology
(1 time)
HB-EGF (2 times)
COPD (1 time)
NF-kappaB (1 time)
2012 Epidermal growth factor: a new therapeutic target in glomerular disease.
24  HB-EGF-induced EGF receptor
(2 times)
Neurology
(1 time)
HB-EGF (2 times)
ADAM17 (1 time)
CsA (1 time)
2012 Cyclosporin A and tacrolimus induce renal Erk1/2 pathway via ROS-induced and metalloproteinase-dependent EGF-receptor signaling.
25  alpha6beta4-EGF receptor
(1 time)
Reproductive Medicine
(1 time)
AR (1 time)
EGF (1 time)
2003 Androgen receptor and prostate cancer invasion.
26  anti-EGFR Ac-Cys-Z
(1 time)
Nuclear Medicine
(1 time)
--- 2012 PET of EGFR expression with an 18F-labeled affibody molecule.
27  anti-endothelial growth factor
(1 time)
Gastroenterology
(1 time)
5-FU (1 time)
mCRC (1 time)
NCCN (1 time)
2012 Treatment decisions after diagnosis of metastatic colorectal cancer.
28  EGF are mediated through the receptor
(1 time)
Biochemistry
(1 time)
--- 2011 MAPK scaffold IQGAP1 binds the EGF receptor and modulates its activation.
29  EGF binds to specific receptors
(1 time)
Cell Biology
(1 time)
--- 2016 Unconventional EGF-induced ERK1/2-mediated Kv1.3 endocytosis.
30  EGF family member
(1 time)
Genes, Neoplasm
(1 time)
Ad (1 time)
2011 Expression of the Adenovirus Early Gene 1A Transcription-Repression Domain Alone Downregulates HER2 and Results in the Death of Human Breast Cancer Cells Upregulated for the HER2 Proto-Oncogene.
31  EGF from EGF receptor
(1 time)
Complementary Therapies
(1 time)
BPH (1 time)
EGF (1 time)
GM-CSF (1 time)
2012 Androgen-independent effects of Serenoa repens extract (Prostasan) on prostatic epithelial cell proliferation and inflammation.
32  EGF, TGF alpha and their receptor
(1 time)
Gynecology
(1 time)
3beta-HSD (1 time)
SCC (1 time)
1995 [Human folliculogenesis and local regulation].
33  EGF/TGF-alpha receptor
(1 time)
Molecular Biology
(1 time)
wa-1 (1 time)
wa-2 (1 time)
1994 The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.
34  EGF/TGF-alpha tyrosine kinase receptor
(1 time)
Cell Biology
(1 time)
Cip1 (1 time)
TGF-alpha (1 time)
2000 The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation.
35  EGFR amplification
(1 time)
General Surgery
(1 time)
GBM (1 time)
TMZ (1 time)
2012 Paradoxical relationship between the degree of EGFR amplification and outcome in glioblastomas.
36  EGFR antibodies
(1 time)
Neoplasms
(1 time)
BUN (1 time)
LP (1 time)
NSCLC (1 time)
2015 A cisplatin‑incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity.
37  EGFR gene
(1 time)
General Surgery
(1 time)
EGFR-TKIs (1 time)
NSCLC (1 time)
p-EGFR (1 time)
2011 The influence of intracellular epidermal growth factor receptor (EGFR) signal activation on the outcome of EGFR tyrosine kinase inhibitor treatment for pulmonary adenocarcinoma.
38  EGFR inhibitor
(1 time)
Biochemistry
(1 time)
COX (1 time)
E2-BSA-FITC (1 time)
OECs (1 time)
2015 Regulation of cyclooxygenase-2 expression in rat oviductal epithelial cells: Evidence for involvement of GPR30/Src kinase-mediated EGFR signaling.
39  EGFR pathway, including erlotinib
(1 time)
CDX (1 time)
Erl-SiTMR-T (1 time)
HNSCC (1 time)
2020 Intracellular paired agent imaging enables improved evaluation of tyrosine kinase inhibitor target engagement.
40  EGFR pharmDX kit
(1 time)
Science
(1 time)
ATC (1 time)
PDTC (1 time)
2004 Epidermal growth factor receptor as a novel therapeutic target in anaplastic thyroid carcinomas.
41  EGFR tyrosine kinase inhibitor
(1 time)
Chemistry Techniques, Analytical
(1 time)
--- 2019 Determination of BPI15086 and its metabolite in human plasma by ultra-high performance liquid chromatography-MS/MS and its application to a pharmacokinetic study.
42  EGFR, as pan-Erb
(1 time)
Vascular Diseases
(1 time)
KSR1 (1 time)
TF (1 time)
2010 Modulation of the oncogene-dependent tissue factor expression by kinase suppressor of ras 1.
43  EGFR-mAbs
(1 time)
Neoplasms
(1 time)
BTC (1 time)
CHT (1 time)
PFS (1 time)
2020 Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis.
44  EGFR-targeting protein, the DOTA-Z
(1 time)
Nuclear Medicine
(1 time)
--- 2010 Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount.
45  EGFRlow
(1 time)
Neoplasms
(1 time)
PC (1 time)
TKI (1 time)
2011 Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.
46  EGFRmut
(1 time)
General Surgery
(1 time)
IHC (1 time)
OS (1 time)
RFS (1 time)
2017 Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma.
47  elegans identified CDT-2 as an attenuator of LET-23
(1 time)
Embryology
(1 time)
--- 2010 The Caenorhabditis elegans CDT-2 ubiquitin ligase is required for attenuation of EGFR signalling in vulva precursor cells.
48  elements of the EV/EP cargo, including oncoproteins
(1 time)
Nanotechnology
(1 time)
AFM (1 time)
EP (1 time)
EV (1 time)
2019 Mapping Subpopulations of Cancer Cell-Derived Extracellular Vesicles and Particles by Nano-Flow Cytometry.
49  encoding the whole isoform a
(1 time)
Neoplasms
(1 time)
Ext-Ab (1 time)
2012 Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain.
50  endothelial growth factor receptors expression
(1 time)
Chemistry
(1 time)
LNCs (1 time)
2013 EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro.
51  endothelial-GF receptor
(1 time)
Male Urogenital Diseases
(1 time)
CG (1 time)
EG (1 time)
FG (1 time)
2015 The effect of penile urethral fat graft application on urethral angiogenesis.
52  enrolled CRC patients treated with antiepidermal growth factor receptor
(1 time)
Medicine
(1 time)
CI (1 time)
CRC (1 time)
HR (1 time)
2017 Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis.
53  epidermal growth factor and its transmembrane receptor
(1 time)
Neoplasms
(1 time)
--- 2008 Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000).
54  epidermal growth factor of upstream receptor
(1 time)
Medicine
(1 time)
--- 2011 [Identification of K-RAS mutations in colorectal cancer patients in Israel].
55  epidermal growth factor tyrosine kinase receptors
(1 time)
Biochemistry
(1 time)
--- 2002 Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH.
56  epidermal growth factor urothelial receptor
(1 time)
Urology
(1 time)
EGF (1 time)
1994 [Quantitative determination of epidermal growth factor urothelial receptor (EGFR) in superficial and invasive bladder carcinoma].
57  epidermal growth factor-like repeats
(1 time)
Brain
(1 time)
CADASIL (1 time)
2009 Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain.
58  epithelial changes after using epidermal
(1 time)
Ophthalmology
(1 time)
FGFR (1 time)
IRB (1 time)
2020 Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors.
59  ErbB family consists of four proteins including
(1 time)
Neoplasms
(1 time)
CRC (1 time)
pEGFR (1 time)
pErbB2 (1 time)
2014 Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
60  erlotinib, gefitinib, cetuximab
(1 time)
Neoplasms
(1 time)
NSCLC (1 time)
VEGF (1 time)
2009 Investigational agents in the management of non-small cell lung cancer.
61  erlotinib, gefitinib, lapatinib
(1 time)
Clinical Trials as Topic
(1 time)
--- 2015 Novel targeted therapies in chordoma: an update.
62  evaluate the gamma-imaging properties of an antiepidermal growth factor receptor
(1 time)
Nuclear Medicine
(1 time)
DTPA (1 time)
PEG (1 time)
ROIs (1 time)
2001 Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
63  evaluate the possibility of treatment with antiepidermal growth factor receptor
(1 time)
Neoplasms
(1 time)
ADCC (1 time)
SCC (1 time)
TGF (1 time)
2007 Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma.
64  evident that growth factor receptors
(1 time)
Cell Biology
(1 time)
CTGF (1 time)
ECM (1 time)
PAI-1 (1 time)
2010 Linking cell structure to gene regulation: signaling events and expression controls on the model genes PAI-1 and CTGF.
65  expression of growth factor
(1 time)
Dentistry
(1 time)
--- 2006 Expression of p53, Ki-67, and EGFR in odontogenic keratocysts before and after decompression.
66  expression of growth factor receptors
(1 time)
Neoplasms
(1 time)
--- 2000 Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients.
67  expression profiles of five parameters as potential mediators in neoangiogenesis
(1 time)
Gastroenterology
(1 time)
--- 2009 Haemorrhoids are related to changes of cell function in mucosa and submucosa.
68  Gurken-EGF receptor
(1 time)
Embryology
(1 time)
EGF (1 time)
2020 Signaling between somatic follicle cells and the germline patterns the egg and embryo of Drosophila.
69  HB-EGF processing or EGF receptor
(1 time)
Science
(1 time)
14,15-EET (1 time)
HB-EGF (1 time)
2002 Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells.
70  include growth factors and their receptors
(1 time)
Gynecology
(1 time)
--- 2009 [Expression of selected angiogenesis markers and modulators in pre-, peri- and postmenopausal women with ovarian cancer].
71  pathways--Epithelial Growth Factor Receptor
(1 time)
Neoplasms
(1 time)
GC (1 time)
MAPK (1 time)
MSI (1 time)
2011 Oncogenic mutations in gastric cancer with microsatellite instability.
72  STAT3-EGF receptor
(1 time)
Neoplasms
(1 time)
CCND1 (1 time)
HA (1 time)
MMP (1 time)
2013 A novel inhibitor of STAT3 homodimerization selectively suppresses STAT3 activity and malignant transformation.